Annual Revenue
$200.52 M
+$72.22 M+56.29%
31 December 2023
Summary:
Pacific Biosciences of California annual revenue is currently $200.52 million, with the most recent change of +$72.22 million (+56.29%) on 31 December 2023. During the last 3 years, it has risen by +$121.63 million (+154.17%). PACB annual revenue is now at all-time high.PACB Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$39.97 M
+$3.95 M+10.98%
30 September 2024
Summary:
Pacific Biosciences of California quarterly revenue is currently $39.97 million, with the most recent change of +$3.95 million (+10.98%) on 30 September 2024. Over the past year, it has dropped by -$15.72 million (-28.23%). PACB quarterly revenue is now -31.51% below its all-time high of $58.36 million, reached on 31 December 2023.PACB Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$173.15 M
-$15.72 M-8.33%
30 September 2024
Summary:
Pacific Biosciences of California TTM revenue is currently $173.15 million, with the most recent change of -$15.72 million (-8.33%) on 30 September 2024. Over the past year, it has increased by +$3.63 million (+2.14%). PACB TTM revenue is now -13.65% below its all-time high of $200.52 million, reached on 31 December 2023.PACB TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PACB Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +56.3% | -28.2% | +2.1% |
| 3 y3 years | +154.2% | +14.6% | +42.4% |
| 5 y5 years | +155.0% | +82.4% | +109.9% |
PACB Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +154.2% | -31.5% | +46.1% | -13.7% | +42.4% |
| 5 y | 5 years | at high | +155.0% | -31.5% | +156.2% | -13.7% | +119.5% |
| alltime | all time | at high | >+9999.0% | -31.5% | >+9999.0% | -13.7% | >+9999.0% |
Pacific Biosciences Of California Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $39.97 M(+11.0%) | $173.15 M(-8.3%) |
| June 2024 | - | $36.01 M(-7.2%) | $188.87 M(-5.8%) |
| Mar 2024 | - | $38.81 M(-33.5%) | $200.43 M(-0.0%) |
| Dec 2023 | $200.52 M(+56.3%) | $58.36 M(+4.8%) | $200.52 M(+18.3%) |
| Sept 2023 | - | $55.69 M(+17.1%) | $169.52 M(+16.0%) |
| June 2023 | - | $47.57 M(+22.3%) | $146.14 M(+9.0%) |
| Mar 2023 | - | $38.90 M(+42.2%) | $134.03 M(+4.5%) |
| Dec 2022 | $128.30 M(-1.7%) | $27.35 M(-15.3%) | $128.30 M(-6.3%) |
| Sept 2022 | - | $32.31 M(-8.9%) | $136.97 M(-1.8%) |
| June 2022 | - | $35.47 M(+6.9%) | $139.55 M(+3.6%) |
| Mar 2022 | - | $33.17 M(-7.9%) | $134.69 M(+3.2%) |
| Dec 2021 | $130.51 M(+65.4%) | $36.02 M(+3.2%) | $130.51 M(+7.3%) |
| Sept 2021 | - | $34.89 M(+14.0%) | $121.63 M(+14.9%) |
| June 2021 | - | $30.61 M(+5.6%) | $105.83 M(+14.7%) |
| Mar 2021 | - | $29.00 M(+6.9%) | $92.29 M(+17.0%) |
| Dec 2020 | $78.89 M(-13.2%) | $27.14 M(+42.2%) | $78.89 M(-1.0%) |
| Sept 2020 | - | $19.08 M(+11.7%) | $79.69 M(-3.4%) |
| June 2020 | - | $17.08 M(+9.5%) | $82.52 M(-8.4%) |
| Mar 2020 | - | $15.60 M(-44.2%) | $90.06 M(-0.9%) |
| Dec 2019 | $90.89 M(+15.6%) | $27.93 M(+27.4%) | $90.89 M(+10.2%) |
| Sept 2019 | - | $21.91 M(-11.0%) | $82.49 M(+4.8%) |
| June 2019 | - | $24.62 M(+49.9%) | $78.73 M(+4.0%) |
| Mar 2019 | - | $16.43 M(-15.9%) | $75.69 M(-3.7%) |
| Dec 2018 | $78.63 M(-15.9%) | $19.53 M(+7.5%) | $78.63 M(-6.4%) |
| Sept 2018 | - | $18.16 M(-15.8%) | $84.03 M(-6.0%) |
| June 2018 | - | $21.58 M(+11.4%) | $89.42 M(+1.7%) |
| Mar 2018 | - | $19.36 M(-22.4%) | $87.92 M(-5.9%) |
| Dec 2017 | $93.47 M(+3.0%) | $24.93 M(+5.9%) | $93.47 M(-0.8%) |
| Sept 2017 | - | $23.55 M(+17.3%) | $94.25 M(-1.6%) |
| June 2017 | - | $20.07 M(-19.4%) | $95.83 M(-0.7%) |
| Mar 2017 | - | $24.91 M(-3.1%) | $96.50 M(+6.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $90.71 M(-2.2%) | $25.72 M(+2.4%) | $90.71 M(-10.4%) |
| Sept 2016 | - | $25.12 M(+21.1%) | $101.27 M(+12.4%) |
| June 2016 | - | $20.75 M(+8.5%) | $90.07 M(-4.4%) |
| Mar 2016 | - | $19.13 M(-47.3%) | $94.26 M(+1.6%) |
| Dec 2015 | $92.78 M(+53.1%) | $36.28 M(+160.7%) | $92.78 M(+26.4%) |
| Sept 2015 | - | $13.92 M(-44.2%) | $73.41 M(-8.4%) |
| June 2015 | - | $24.94 M(+41.3%) | $80.11 M(+20.3%) |
| Mar 2015 | - | $17.64 M(+4.4%) | $66.60 M(+9.9%) |
| Dec 2014 | $60.59 M(+115.0%) | $16.90 M(-18.0%) | $60.59 M(+14.7%) |
| Sept 2014 | - | $20.62 M(+80.5%) | $52.82 M(+33.3%) |
| June 2014 | - | $11.43 M(-1.9%) | $39.62 M(+15.7%) |
| Mar 2014 | - | $11.64 M(+27.5%) | $34.24 M(+21.5%) |
| Dec 2013 | $28.18 M(+8.5%) | $9.13 M(+23.1%) | $28.18 M(+13.1%) |
| Sept 2013 | - | $7.42 M(+22.7%) | $24.93 M(+22.9%) |
| June 2013 | - | $6.05 M(+8.4%) | $20.28 M(-5.8%) |
| Mar 2013 | - | $5.58 M(-5.1%) | $21.52 M(-17.2%) |
| Dec 2012 | $25.98 M(-23.3%) | $5.88 M(+111.7%) | $25.98 M(-20.2%) |
| Sept 2012 | - | $2.78 M(-61.9%) | $32.55 M(-19.2%) |
| June 2012 | - | $7.29 M(-27.4%) | $40.29 M(-7.7%) |
| Mar 2012 | - | $10.04 M(-19.3%) | $43.63 M(+28.8%) |
| Dec 2011 | $33.86 M(+1922.9%) | $12.44 M(+18.3%) | $33.86 M(+56.1%) |
| Sept 2011 | - | $10.52 M(-1.0%) | $21.70 M(+90.3%) |
| June 2011 | - | $10.63 M(+3837.0%) | $11.40 M(+714.9%) |
| Mar 2011 | - | $270.00 K(-3.6%) | $1.40 M(-16.4%) |
| Dec 2010 | $1.67 M(+1140.0%) | $280.00 K(+27.3%) | $1.67 M(+9.5%) |
| Sept 2010 | - | $220.00 K(-65.0%) | $1.53 M(+16.8%) |
| June 2010 | - | $629.00 K(+15.4%) | $1.31 M(+92.5%) |
| Mar 2010 | - | $545.00 K(+303.7%) | $680.00 K(+403.7%) |
| Dec 2009 | $135.00 K(-85.0%) | $135.00 K | $135.00 K |
| Dec 2008 | $901.00 K(-58.3%) | - | - |
| Dec 2007 | $2.16 M | - | - |
FAQ
- What is Pacific Biosciences of California annual revenue?
- What is the all time high annual revenue for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual revenue year-on-year change?
- What is Pacific Biosciences of California quarterly revenue?
- What is the all time high quarterly revenue for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly revenue year-on-year change?
- What is Pacific Biosciences of California TTM revenue?
- What is the all time high TTM revenue for Pacific Biosciences of California?
- What is Pacific Biosciences of California TTM revenue year-on-year change?
What is Pacific Biosciences of California annual revenue?
The current annual revenue of PACB is $200.52 M
What is the all time high annual revenue for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual revenue is $200.52 M
What is Pacific Biosciences of California annual revenue year-on-year change?
Over the past year, PACB annual revenue has changed by +$72.22 M (+56.29%)
What is Pacific Biosciences of California quarterly revenue?
The current quarterly revenue of PACB is $39.97 M
What is the all time high quarterly revenue for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly revenue is $58.36 M
What is Pacific Biosciences of California quarterly revenue year-on-year change?
Over the past year, PACB quarterly revenue has changed by -$15.72 M (-28.23%)
What is Pacific Biosciences of California TTM revenue?
The current TTM revenue of PACB is $173.15 M
What is the all time high TTM revenue for Pacific Biosciences of California?
Pacific Biosciences of California all-time high TTM revenue is $200.52 M
What is Pacific Biosciences of California TTM revenue year-on-year change?
Over the past year, PACB TTM revenue has changed by +$3.63 M (+2.14%)